Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Vascepa
Pharma
Teva, like Hikma, accuses Amarin of hoarding Vascepa ingredient
In a new lawsuit, Teva flagged Amarin’s “anti-competitive conduct to prevent and delay generic competition” to Vascepa—a fish-oil-derived heart med.
Fraiser Kansteiner
Mar 29, 2024 1:10pm
Amarin axes 120 of its 385 employees, hires new CEO Patrick Holt
Jul 19, 2023 10:45am
After Amarin's clash with Sarissa, CEO Karim Mikhail hits exit
Mar 31, 2023 11:14am
With 7 board resignations, Sarissa strengthens control of Amarin
Mar 7, 2023 10:30am
Hikma says Amarin inked supply deals to shut out generics
Feb 23, 2023 2:20pm
Activist Sarissa claps back at Amarin as board vote nears
Feb 13, 2023 4:51pm